<DOC>
	<DOCNO>NCT02708771</DOCNO>
	<brief_summary>Assess whether high dos ? -3 fatty acid add standard treatment patient acute hearta failure , hypoalbuminemia high inflammatory activity , promote increase serum albumin</brief_summary>
	<brief_title>Effect W-3 Polyunsaturated Fatty Acids Serum Albumin Concentration Patients With Acute Heart Failure , Hypoalbuminemia , High Inflammatory Activity</brief_title>
	<detailed_description>Assess whether high dos ? -3 fatty acid add standard treatment patient acute hearta failure , hypoalbuminemia high inflammatory activity , promote increase serum albumin Assess effect high dos ? -3 fatty acid add standard treatment patient acute hearta failure , hypoalbuminemia high inflammatory activity : - Inflammatory activity ( C-reactive protein ) - The development biomarkers ( NTproBNP ) . - The prognosis patient evaluate combined event death cause readmission heart failure within three month randomization .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypoalbuminemia</mesh_term>
	<mesh_term>Eicosapentaenoic acid ethyl ester</mesh_term>
	<criteria>Patients age 18 year olders hospitalize acute heart failure , chronic decompensated new onset etiology , present hypoalbuminemia ( serum albumin ? 3,4 g / dl ) high inflammatory activity ( CRP ? 2,5 mg / dl ) . Impending doom Participating clinical trial Treatment ? 3 acid last month prior admission Percutaneous surgical treatment cause heart failure hospitalization . Pregnant woman . Renal failure dialysis . Chronic liver disease ChildPugh B C. Acute infectious process . Active malignant neoplasia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>